This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
OKYO Pharma Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
OKYO Pharma has been growing earnings at an average annual rate of 39.4%, while the Biotechs industry saw earnings growing at 7.2% annually.
Anahtar bilgiler
39.4%
Kazanç büyüme oranı
62.4%
EPS büyüme oranı
| Biotechs Sektör Büyümesi | 11.5% |
| Gelir büyüme oranı | n/a |
| Özkaynak getirisi | n/a |
| Net Marj | n/a |
| Son Kazanç Güncellemesi | 30 Sep 2022 |
Yakın geçmiş performans güncellemeleri
Güncelleme yok
Recent updates
Can OKYO Pharma (LON:OKYO) Afford To Invest In Growth?
Nov 26
Is OKYO Pharma (LON:OKYO) In A Good Position To Deliver On Growth Plans?
Jan 27Here's Why We're Not At All Concerned With OKYO Pharma's (LON:OKYO) Cash Burn Situation
Sep 22We Think OKYO Pharma (LON:OKYO) Can Easily Afford To Drive Business Growth
Mar 17We're Interested To See How OKYO Pharma (LON:OKYO) Uses Its Cash Hoard To Grow
Dec 02Gelir ve Gider Dağılımı
OKYO Pharma nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 22 | 0 | -7 | 0 | 3 |
| 30 Jun 22 | 0 | -5 | 0 | 2 |
| 31 Mar 22 | 0 | -4 | 0 | 1 |
| 31 Dec 21 | 0 | -4 | 0 | 1 |
| 30 Sep 21 | 0 | -4 | 0 | 0 |
| 30 Jun 21 | 0 | -3 | 0 | 0 |
| 31 Mar 21 | 0 | -3 | 0 | 0 |
| 31 Dec 20 | 0 | -1 | 0 | 0 |
| 30 Sep 20 | 0 | 0 | 0 | 0 |
| 30 Jun 20 | 0 | -1 | 0 | 0 |
| 31 Mar 20 | 0 | -1 | 0 | 0 |
| 31 Dec 19 | 0 | -3 | 0 | 1 |
| 30 Sep 19 | 0 | -4 | 0 | 2 |
| 30 Jun 19 | 0 | -4 | 0 | 2 |
| 31 Mar 19 | 0 | -4 | 0 | 2 |
| 31 Dec 18 | 0 | -3 | 0 | 1 |
| 30 Sep 18 | 0 | -2 | 0 | 1 |
| 30 Jun 18 | 0 | -11 | 0 | 1 |
| 31 Mar 18 | 0 | -20 | 0 | 0 |
| 31 Dec 17 | 0 | -20 | 0 | 0 |
| 30 Sep 17 | 0 | -19 | 0 | 0 |
| 30 Jun 17 | 0 | -10 | 0 | 0 |
| 31 Mar 17 | 0 | 0 | 0 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
| 30 Sep 16 | 0 | 0 | 1 | 0 |
Kaliteli Kazançlar: OKYO is currently unprofitable.
Büyüyen Kar Marjı: OKYO is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: OKYO is unprofitable, but has reduced losses over the past 5 years at a rate of 39.4% per year.
Büyüme Hızlandırma: Unable to compare OKYO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: OKYO is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-7%).
Özkaynak Getirisi
Yüksek ROE: OKYO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.